United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Wealthtime and Wipro join forces to transform adviser platforms In a strategic move set to reshape adviser platforms, Wealthtime has joined hands with Wipro and its technology… byPallavi MadhirajuOctober 28, 2024